Evidence map›Paper›PMID 41884082›Full record

ArticleTobacco induced diseases2026

A pilot stratified cluster randomized trial of school-based e-cigarette and other tobacco product use prevention for Pacific Island youths: An evaluation of the Fuetsan Manhoben curriculum.

Francis Dalisay, Scott K Okamoto, Yoshito Kawabata, Thaddeus A Herzog, Pallav Pokhrel

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05037656 (University of Guam/University of Hawaii Cancer Center Partnership for Cancer Health Equity, Full Project I), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05037656 nacompletednot on this map

University of Guam/University of Hawaii Cancer Center Partnership for Cancer Health Equity, Full Project I: Developing and Testing a School-Based Curriculum for E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention for Guam Youths

TypeinterventionalSponsorUniversity of GuamRan2022 to 2025Enrolled538ConditionsTobacco Smoking, Vaping, Tobacco ChewingArmsSchool-based curriculum
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Francis DalisayCollege of Journalism and Communications, STEM Translational Communication Center, University of Florida, Gainesville, United States.
Scott K OkamotoPopulation Sciences in the Pacific Program, University of Hawai'i Cancer Center, Honolulu, United States.
Yoshito KawabataSocial and Behavioral Sciences Division, College of Liberal Arts and Social Sciences, University of Guam, Mangilao, Guam, United States.
Thaddeus A HerzogPopulation Sciences in the Pacific Program, University of Hawai'i Cancer Center, Honolulu, United States.
Pallav PokhrelPopulation Sciences in the Pacific Program, University of Hawai'i Cancer Center, Honolulu, United States.

Funding

University of Guam/Cancer Research Center of Hawaii Partnership (2 of 2)U54CA143728 · NCI · UNIVERSITY OF GUAM · PI Laura Biggs · 2009 to 2026
$20.1M
University of Guam/Cancer Research Center of Hawaii Partnership (1 of 2)U54CA143727 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI LYNNE R WILKENS · 2009 to 2026
$19.1M
NCI NIH HHS U54 CA143727NCI NIH HHS U54 CA143728
6 · The paper itself

Abstract

introductionE-cigarette use among young adolescents in Guam, and potentially other regions of the US-Affiliated Pacific Islands (USAPI), is markedly higher than among similarly aged adolescents in the general US population. The objective was to test the pilot version of a school-based e-cigarette and other tobacco product curriculum, named

methodsThe intervention involved 4 video-based, culturally tailored lessons delivered in the classroom by health educators. A stratified cluster-randomized design was used to assign 8 public middle schools to either the intervention or the control condition. Six classrooms in each school participated in the study. Participants (n=269) in the intervention condition received the 4-lesson curriculum, whereas participants (n=269) in the control condition did not receive any intervention. Participants in both conditions provided data at pretest, post-test (4 weeks later), and at follow-up at 3 months. The current analyses pertain only to e-cigarette-related outcomes. Wald tests were utilized to determine the statistical significance of fixed effects within the negative binomial and logistic regression frameworks.

resultsAt immediate post-test, the intervention did not have statistically significant effects on openness to using e-cigarettes (incidence rate ratio, IRR=0.79; 95% CI: 0.42-1.49, p>0.05), e-cigarette use initiation (OR=O.96; 95% CI: 0.42-2.19, p>0.05), or past-30-day e-cigarette use (IRR=0.90; 95% CI: 0.77-1.06, p>0.05). At follow-up at 3 months, the intervention also did not have statistically significant effects on e-cigarette use initiation (OR=0.70; 95% CI: 0.34-1.45, p>0.05) or past-30-day e-cigarette use (IRR=0.94; 95% CI: 0.82-1.08, p>0.05). However, findings indicated that the intervention reduced openness to using e-cigarettes at follow-up at 3 months (IRR=0.49; 95% CI: 0.28-0.86, p<0.01). That is, being assigned to the intervention condition was associated with 51% decrease in openness to using e-cigarettes at follow-up at 3 months.

conclusionsFour lessons delivered over 4 weeks may not produce immediate short-term preventive effects, except potentially reducing e-cigarette use susceptibility at follow-up at 3 months. Further research is warranted to examine whether expanding the content and duration of the curriculum may result in stronger, more durable effects. Also, future studies should examine whether increasing the follow-up to 6-12 months might capture delayed preventive effects that were not detectable within the shortened, follow-up at 3 months in the current study. CLINICAL

trial registrationThe study is registered on the official website of ClinicalTrials.gov. IDENTIFIER: ID NCT05037656.

Indexed as

adolescentscurriculume-cigarettepacific islanderschool-based

Identifiers

PMID41884082
PMCPMC13012013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.